Cargando…

Cholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong Problem

See Article Duncan et al

Detalles Bibliográficos
Autores principales:	Gidding, Samuel S., Allen, Norrina B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585375/ https://www.ncbi.nlm.nih.gov/pubmed/31137996 http://dx.doi.org/10.1161/JAHA.119.012924

Ejemplares similares

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

The Ratio of Triglyceride to High-density Lipoprotein Cholesterol as an Indicator of Risk Stratification for Atherosclerotic Cardiovascular Disease in a Clinical Setting
por: Tani, Shigemasa
Publicado: (2020)

Association of Health-Related Quality of Life with Atherosclerotic Cardiovascular Disease: Lifetime Risk Pooling Project
por: Ning, Hongyan, et al.
Publicado: (2021)

Social Network Structure and Atherosclerotic Cardiovascular Disease
por: Nishi, Nobuo
Publicado: (2018)

Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol
por: Roy, Satyajeet
Publicado: (2014)

Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy
por: Chiang, John Y. L., et al.
Publicado: (2020)

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
por: Doi, Takahito, et al.
Publicado: (2023)

SIRT1 and Gender Differences in Atherosclerotic Cardiovascular Disease
por: Shimabukuro, Michio
Publicado: (2020)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

A Risk Prediction Model of Atherosclerotic Cardiovascular Disease in Japan
por: Saito, Isao
Publicado: (2022)

Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies
por: Jeras, Jernej, et al.
Publicado: (2022)

Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learning
por: Yu, Jingzhi, et al.
Publicado: (2023)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China()
por: Hu, Da-Yi
Publicado: (2016)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Integrated Role of Nutrition and Physical Activity for Lifelong Health
por: Koehler, Karsten, et al.
Publicado: (2019)

Ten Simple Rules for Lifelong Learning, According to Hamming
por: Erren, Thomas C., et al.
Publicado: (2015)

C. Richard Conti—Lifelong learning: Advocacy and implementation
por: Wenger, Nanette K.
Publicado: (2022)

Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study
por: Wadström, Benjamin N., et al.
Publicado: (2023)

Carotid atherosclerotic disease
por: Sitrângulo, Cid José, et al.
Publicado: (2018)

L-Arginine, Nitric Oxide, and Endothelial Dysfunction Underlying Atherosclerotic Cardiovascular Disease (ASCVD)
por: Shimabukuro, Michio
Publicado: (2023)

Are we underestimating the lifelong benefits of therapy for obstructive sleep apnea?
por: Berman, Alec M, et al.
Publicado: (2016)

Exercise Biomechanics for Health: Evaluating Lifelong Activities for Well-Being
por: Forte, Pedro, et al.
Publicado: (2023)

Lifelong statins for long life in dialysis patients?
por: Ebert, Thomas, et al.
Publicado: (2023)

To be Functional, or not to be Low in Cholesterol, that is the Clinical Concern when Evaluating Anti-Atherosclerotic Actions of High-Density Lipoproteins
por: Yoshida, Hiroshi
Publicado: (2021)

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
por: Poels, Kikkie, et al.
Publicado: (2021)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Current Status of Low-Density Lipoprotein Cholesterol and Cardiovascular Diseases in Japan
por: Sun, Wanlu, et al.
Publicado: (2023)

Cholesterol Paradigm and Beyond in Atherosclerotic Cardiovascular Disease: Cholesterol, Sterol Regulatory Element-Binding Protein, Inflammation, and Vascular Cell Mobilization in Vasculopathy
por: Zhou, Ruihai, et al.
Publicado: (2021)

Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations
por: Lütjohann, Dieter, et al.
Publicado: (2023)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Beyond the Valve: Lifelong Management of Right Ventricular Outflow Tract Lesion in Adult Congenital Heart Disease
por: Lee, Chang-Ha
Publicado: (2022)

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
por: Mani, Venkatesh, et al.
Publicado: (2009)

Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis
por: González-Gay, Miguel A, et al.
Publicado: (2012)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
por: Okerson, Ted, et al.
Publicado: (2017)

Genetic Variations, Triglycerides, and Atherosclerotic Disease
por: Tada, Hayato, et al.
Publicado: (2019)

In sickness and in health, till death do us part: Is the ICD a lifelong commitment?
por: Rajabali, A., et al.
Publicado: (2017)

Can Barker's Hypothesis Explain the Observed Different Trends of Mortality from Atherosclerotic Cardiovascular Disease in Western Europe?
por: Ghafari, Mahin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ilnn1npc3d1rk2qmehta637ek4